Back |
home / stock / rvvtf / rvvtf message board
Subject | By | Source | When |
---|---|---|---|
mc67: $RVVTF Revive Therapeutics Signs MOU with Attwill Medical Solutions for Phase 3 Clinical Trial | mc67 | investorshangout | 08/14/2020 1:37:23 PM |
shalbyj: RVVTF - Revive Therapeutics Gains Solid Momentum: How To Trade Now https://pennystocks.news | shalbyj | investorshangout | 08/10/2020 2:51:03 PM |
mc67: $RVVTF Fress DD: Covid destroying Heart tissue RVVTF Bucillamine might have multiple target in | mc67 | investorshangout | 08/09/2020 9:23:26 AM |
mc67: $RVVTF UPDATE: REVIVE THERAPEUTIC FUNDAMENTAL DD... By Powerbattles (copy) The Shocking Truth | mc67 | investorshangout | 08/09/2020 9:13:26 AM |
News, Short Squeeze, Breakout and More Instantly...
Revive Therapeutics Ltd. Company Name:
RVVTF Stock Symbol:
OTCMKTS Market:
Revive Therapeutics Ltd. Website:
TORONTO, July 02, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases,...
TORONTO, June 12, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases,...
TORONTO, June 10, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases,...